XML 24 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Instruments and Fair Value
12 Months Ended
Jan. 31, 2023
Investments, All Other Investments [Abstract]  
Financial Instruments and Fair Value

3. Financial Instruments and Fair Value

In the second quarter of fiscal year 2023, the Company resumed its investments in money market funds and debt securities after a full liquidation of its investments in fiscal year 2022 to finance the acquisition of Oculii. The debt security investment portfolio consists of commercial paper, debt securities of corporations or corporate bonds, asset-backed securities and U.S. government securities. All of the investments are denominated in United States dollars and reported at fair value as available-for-sale securities in the consolidated balance sheets as follows:

 

 

 

As of January 31, 2023

 

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

 

 

(in thousands)

 

Money market funds

 

$

7,872

 

 

$

 

 

$

 

 

$

7,872

 

Commercial paper

 

 

18,333

 

 

 

 

 

 

 

 

 

18,333

 

Corporate bonds

 

 

23,472

 

 

 

50

 

 

 

(224

)

 

 

23,298

 

Asset-backed securities

 

 

18,753

 

 

 

44

 

 

 

(149

)

 

 

18,648

 

U.S. government securities

 

 

33,256

 

 

 

22

 

 

 

(235

)

 

 

33,043

 

Total cash equivalents and marketable debt securities

 

$

101,686

 

 

$

116

 

 

$

(608

)

 

$

101,194

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of January 31, 2022

 

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

 

 

(in thousands)

 

Money market funds

 

$

20

 

 

$

 

 

$

 

 

$

20

 

Total cash equivalents and marketable debt securities

 

$

20

 

 

$

 

 

$

 

 

$

20

 

 

As of January 31, 2023, there were no money market funds or debt securities with unrealized losses for more than twelve months.

 

 

 

As of

 

 

 

January 31, 2023

 

 

January 31, 2022

 

 

 

(in thousands)

 

Included in cash equivalents

 

$

7,872

 

 

$

20

 

Included in marketable debt securities

 

 

93,322

 

 

 

 

Total cash equivalents and marketable debt securities

 

$

101,194

 

 

$

20

 

 

 

The contractual maturities of the investments at January 31, 2023 and 2022 were as follows:

 

 

 

As of

 

 

 

January 31, 2023

 

 

January 31, 2022

 

 

 

(in thousands)

 

Due within one year

 

$

48,016

 

 

$

20

 

Due in 1-5 years

 

 

52,414

 

 

 

 

Due in 5-7 years

 

 

764

 

 

 

 

Total cash equivalents and marketable debt securities

 

$

101,194

 

 

$

20

 

 

The unrealized gains and losses on the available-for-sale securities were primarily caused by fluctuations in market value and interest rates as a result of the economic environment. In accordance with ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, the Company estimates the expected losses at an individual security level whenever a security’s fair value is below its amortized cost basis using the discounted cash flow method. The credit-related portion of the loss is recognized in other income, net in the consolidated statements of operations but is limited to the difference between the fair value and the amortized cost basis of the security, adjusted for accrued interest. The non-credit-related portion of the loss is recognized in accumulated other comprehensive loss in the consolidated balance sheets. The credit-related losses were not material for the fiscal years ended January 31, 2023, 2022 and 2021, respectively.

 

Interest income, including amortization of premiums and accretion of discounts related to the investments, as well as realized gains and losses from sales of the investments are recorded in other income, net, in the consolidated statements of operations. For the fiscal years ended January 31, 2023, 2022, and 2021, interest income and realized gains and losses, net, were approximately $1.7 million, $1.7 million and $3.6 million, respectively.

The following fair value hierarchy is applied for disclosure of the inputs used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:

Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments.

Level 3—Unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation.

The Company measures the fair value of money market funds using quoted prices in active markets for identical assets and classifies them within Level 1. The fair value of the Company’s investments in other debt securities are obtained based on quoted prices for similar assets in active markets and are classified within Level 2.

The following tables present the fair value of the financial instruments measured on a recurring basis as of January 31, 2023 and 2022, respectively:

 

 

 

As of January 31, 2023

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

(in thousands)

 

Money market funds

 

$

7,872

 

 

$

7,872

 

 

$

 

 

$

 

Commercial paper

 

 

18,333

 

 

 

 

 

 

18,333

 

 

 

 

Corporate bonds

 

 

23,298

 

 

 

 

 

 

23,298

 

 

 

 

Asset-backed securities

 

 

18,648

 

 

 

 

 

 

18,648

 

 

 

 

U.S. government securities

 

 

33,043

 

 

 

 

 

 

33,043

 

 

 

 

Total cash equivalents and marketable debt securities

 

$

101,194

 

 

$

7,872

 

 

$

93,322

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of January 31, 2022

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

(in thousands)

 

Money market funds

 

$

20

 

 

$

20

 

 

$

 

 

$

 

Total cash equivalents and marketable debt securities

 

$

20

 

 

$

20

 

 

$

 

 

$